Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Beginning Cash Balance (2017 - 2020)

Historic Beginning Cash Balance for Northwest Biotherapeutics (NWBO) over the last 9 years, with Q4 2020 value amounting to $315000.0.

  • Northwest Biotherapeutics' Beginning Cash Balance changed N/A to $315000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $379000.0, marking a year-over-year increase of 1519.76%. This contributed to the annual value of $379000.0 for FY2020, which is 1519.76% up from last year.
  • According to the latest figures from Q4 2020, Northwest Biotherapeutics' Beginning Cash Balance is $315000.0.
  • In the past 5 years, Northwest Biotherapeutics' Beginning Cash Balance ranged from a high of $764000.0 in Q3 2017 and a low of $41000.0 during Q4 2018
  • Over the past 4 years, Northwest Biotherapeutics' median Beginning Cash Balance value was $322000.0 (recorded in 2019), while the average stood at $352500.0.
  • Examining YoY changes over the last 5 years, Northwest Biotherapeutics' Beginning Cash Balance showed a top increase of 25466.67% in 2018 and a maximum decrease of 8828.57% in 2018.
  • Quarter analysis of 4 years shows Northwest Biotherapeutics' Beginning Cash Balance stood at $350000.0 in 2017, then crashed by 88.29% to $41000.0 in 2018, then surged by 702.44% to $329000.0 in 2019, then decreased by 4.26% to $315000.0 in 2020.
  • Its last three reported values are $315000.0 in Q4 2020, $64000.0 for Q1 2020, and $329000.0 during Q1 2019.